# A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Rela

Source: https://onco.cc/trials/nct06911502/  
OnCo record `nct06911502` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Golcadomide, Rituximab, Lenalidomide in follicular lymphoma, run by Celgene, now recruiting.

## Summary

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4) is a phase 3 interventional study registered as NCT06911502 by Celgene, with 400 participants planned, started 2025-07-28 and due to reach its primary completion in 2028-04-24. Interventions recorded: Golcadomide, Rituximab, Lenalidomide, Cyclophosphamide, Doxorubicin. Conditions listed: Follicular Lymphoma. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06911502
- Phase: 3
- Setting: A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) Vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy
- Sponsor: Celgene
- Enrolled: 400

## Sources

- ClinicalTrials.gov NCT06911502: https://clinicaltrials.gov/study/NCT06911502

## Connected records

- cancers: [Follicular lymphoma](https://onco.cc/cancers/follicular-lymphoma/)
- drugs: [Cyclophosphamide](https://onco.cc/drugs/cyclophosphamide/), [Doxorubicin](https://onco.cc/drugs/doxorubicin/), [Golcadomide](https://onco.cc/drugs/golcadomide/), [Lenalidomide](https://onco.cc/drugs/lenalidomide/), [Rituximab](https://onco.cc/drugs/rituximab/), [Vincristine](https://onco.cc/drugs/vincristine/)
- companies: [Bristol Myers Squibb](https://onco.cc/companies/bms/)

---
JSON: https://onco.cc/api/v1/entities/nct06911502.json